Skip to main content
Log in

Impact of hypoxic hepatitis on mortality in the intensive care unit

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Purpose

Hypoxic hepatitis (HH) is a form of hepatic injury following arterial hypoxemia, ischemia, and passive congestion of the liver. We investigated the incidence and the prognostic implications of HH in the medical intensive care unit (ICU).

Methods

A total of 1,066 consecutive ICU admissions at three medical ICUs of a university hospital were included in this prospective cohort study. All patients were screened prospectively for the presence of HH according to established criteria. Independent risk factors of mortality in this cohort of critically ill patients were identified by a multivariate Poisson regression model.

Results

A total of 118 admissions (11%) had HH during their ICU stay. These patients had different baseline characteristics, longer median ICU stay (8 vs. 6 days, p < 0.001), and decreased ICU survival (43 vs. 83%, p < 0.001). The crude mortality rate ratio of admissions with HH was 4.62 (95% CI 3.63–5.86, p < 0.001). Regression analysis demonstrated strong mortality risk for admissions with HH requiring vasopressor therapy (adjusted rate ratio 4.91; 95% CI 2.51–9.60, p < 0.001), whereas HH was not significantly associated with mortality in admissions without vasopressor therapy (adjusted rate ratio 1.79, 95% CI 0.52–6.23, p = 0.359).

Conclusions

Hypoxic hepatitis (HH) occurs frequently in the medical ICU. The presence of HH is a strong risk factor for mortality in the ICU in patients requiring vasopressor therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ALT:

Serum alanine transaminase

AST:

Serum aspartate transaminase

CI:

Confidence interval

ICU:

Intensive care unit

IQR:

Interquartile range

HH:

Hypoxic hepatitis

RR:

Rate ratio

SAPS:

Simplified acute physiology score

References

  1. Fuchs S, Bogomolski-Yahalom V, Paltiel O, Ackerman Z (1998) Ischemic hepatitis. Clinical and laboratory observations of 34 patients. J Clin Gastroenterol 26:183–186

    Article  PubMed  CAS  Google Scholar 

  2. Henrion J, Schapira M, Luwart L, Colin L, Delannoy A, Heller FR (2003) Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine 82:392–406

    Article  PubMed  Google Scholar 

  3. Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Kitzberger R, Warszawska J, Holzinger U, Schenk P, Madl C (2009) Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 35:1397–1405

    Article  PubMed  Google Scholar 

  4. Thomson SJ, Cowan ML, Johnston I, Musa S, Grounds M, Rahman TM (2009) “Liver function tests” on the intensive care unit: a prospective, observational study. Intensive Care Med 35:1406–1411

    Article  PubMed  CAS  Google Scholar 

  5. Kramer L, Jordan B, Druml W, Bauer P, Metnitz PG, Austrian Epidemiologic Study on Intensive Care, ASDI Study Group (2007) Incidence and prognosis of early hepatic funciton in critically ill patients—a prospective multicenter study. Crit Care Med 35:1099–1104

    Article  PubMed  Google Scholar 

  6. Birrer R, Takuda Y, Takara T (2007) Hypoxic hepatopathy: pathophysiology and prognosis. Intern Med 46:1063–1070

    Article  PubMed  Google Scholar 

  7. Ebert E (2006) Hypoxic liver injury. Mayo Clin Proc 81:1232–1236

    Article  PubMed  Google Scholar 

  8. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93:841–842

    Article  PubMed  CAS  Google Scholar 

  9. Gibson PR, Dudely F (1984) Ischemic hepatitis: clinical features, diagnosis and prognosis. Aust N Z J Med 14:825–922

    Google Scholar 

  10. Gitlin N, Serio K (1992) Ischemic hepatitis: widening horizons. Am J Gastroenterol 87:831–836

    PubMed  CAS  Google Scholar 

  11. Hickman PE, Potter J (1990) Mortality associated with ischemic hepatitis. Aust N Z J Med 20:32–34

    PubMed  CAS  Google Scholar 

  12. Rawson JS, Achord J (1985) Shock liver. South Med J 78:1421–1425

    Article  PubMed  CAS  Google Scholar 

  13. Seeto RK, Fenn B, Rockey DC (2000) Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 109:109–113

    Article  PubMed  CAS  Google Scholar 

  14. Whitehead MW, Hawkes ND, Hainsworth I, Kingham JG (1999) A prospective study of the causes of notably raised aspartate aminotransferases of liver origin. Gut 45:129–133

    Article  PubMed  CAS  Google Scholar 

  15. Gillum BS, Graves E, Kozak LJ (1989) Vital and health statistics. Trends in hospital utilization: United States 1965–86. Vital Health Stat 13:1–57

    Google Scholar 

  16. Martin GS, Mannino D, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 to 2000. N Engl J Med 348:1546–1554

    Article  PubMed  Google Scholar 

  17. Waikar SS, Curhan G, Wald R, McCarthy EP, Chertow GM (2006) Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol 17:1143–1150

    Article  PubMed  Google Scholar 

  18. Annane D, Aegerter P, Jars-Guincestre MC, B Guidet for the CUB-Rea Network (2003) Current epidemiology of septic shock. Am J Respir Crit Care Med 168:165–172

    Article  PubMed  Google Scholar 

  19. Johnson RD, O′Connor C, Kerr M (1995) Extreme serum elevations of aspirate aminotransferase. Am J Gastroenterol 90:1244–1245

    PubMed  CAS  Google Scholar 

  20. Fuhrmann V, Madl C, Mueller C, Holzinger U, Kitzberger R, Funk GC, Schenk P (2006) Hepatopulmonary syndrome in patients wit hypoxic hepatitis. Gastroenterology 131:69–75

    Article  PubMed  Google Scholar 

  21. Hirsch LJ, Ayabe T, Glick G (1976) Direct effects of various catecholamines on liver circulation in dogs. Am J Physiol 230:1394–1399

    PubMed  CAS  Google Scholar 

  22. Reilly FD, McCuseky R, Cilento EV (1981) Hepatic microvascular regulatory mechanism. I. Adrenergic mechanis. Microvasc Res 21:103–116

    Article  PubMed  CAS  Google Scholar 

  23. Krejci V, Hiltebrand L, Sigurdson GH (2006) Effect of epinephrine, norepinephrine, and phenylepinephrine on microvascular blood flow in the gastrointestinal tract in sepsis. Crit Care Med 34:1456–1463

    Article  PubMed  CAS  Google Scholar 

  24. Mehrabi A, Golling M, Kashfi A, Boucsein T, Schemmer P, Gutt CN, Schmidt J, Büchler MW, Kraus TW (2005) Negative impact of systemic catecholamine administration on hepatic blood perfusion after porcine liver transplantation. Liver Transpl 11:174–187

    Article  PubMed  Google Scholar 

  25. Aninat C, Seguin P, Descheemaeker PN, Morel F, Malledant Y, Guillouzo A (2008) Catecholamines induce an inflammatory response in human hepatocytes. Crit Care Med 36:848–854

    Article  PubMed  CAS  Google Scholar 

  26. Fuhrmann V, Jäger B, Zubkova A, Drolz A (2010) Hypoxic hepatitis-epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr 122:129–139

    Article  PubMed  Google Scholar 

  27. Nielsen VG, Tan S, Baird MS, Samuelson PN, McCammon AT, Parks DA (1997) Xanthine oxidase mediates myocardial injury after hepatoenteric ischemia–reperfusion. Crit Care Med 25:1044–1050

    Article  PubMed  CAS  Google Scholar 

  28. Peralta C, Perales JC, Bartrons R, Mitchell C, Gilgenkrantz H, Xaus C, Prats N, Fernández L, Gelpí E, Panés J, Roselló-Catafau J (2002) The combination of ischemic preconditioning and liver Bcl-2 over expression is a suitable strategy to prevent liver and lung damage after hepatic ischemia–reperfusion. Am J Pathol 160:2111–2122

    Article  PubMed  CAS  Google Scholar 

  29. Jiang H, Meng F, Li W, Tong L, Qiao H, Sun X (2007) Splenectomy ameliorates acute multiple organ damage induced by warm ischemia reperfusion in rats. Surgery 141:32–40

    Article  PubMed  Google Scholar 

  30. Szabo G, Romics L, Frendl G (2002) Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis 6:1045–1066

    Article  PubMed  Google Scholar 

  31. Antoniades CG, Berry PA, Wendon JA, Vergani D (2008) The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol 49:845–861

    Article  PubMed  CAS  Google Scholar 

  32. Sakka S, von Hout N (2006) Relation between indocyanine green clearance (ICG) plasma disappearance rate and ICG blood clearance in critically ill patients. Intensive Care Med 32:766–769

    Article  PubMed  CAS  Google Scholar 

  33. Sakka S, Reinhart K, Meier-Hellmann A (2002) Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest 122:1715–1720

    Article  PubMed  Google Scholar 

  34. Dresing K, Armstrong VW, Leip CL, Streit F, Burchardi H, Stürmer KM, Oellerich M (2007) Real-time assessment of hepatic function is related to clinical outcome in critically ill patients after polytrauma. Clin Biochem 40:1194–2000

    Article  PubMed  CAS  Google Scholar 

  35. Henrion J, Descamps O, Luwaert R, Schapira M, Parfonry A, Heller F (1994) Hypoxic hepatitis in patients with cardiac failure: incidence in a coronary care unit and measurement of hepatic blood flow. J Hepatol 21:696–703

    Article  PubMed  CAS  Google Scholar 

  36. Naschitz JE, Yeshurun D (1987) Compensated cardiogenic shock: a subset with damage limited to liver and kidneys. The possible salutary effect of low-dose dopamine. Cardiology 74:212–218

    Article  PubMed  CAS  Google Scholar 

  37. Guo L, Richardson KS, Tucker LM, Doll MA, Hein DW, Arteel GE (2004) Role of the renin-angiotensin system in hepatic ischemia reperfusion injury in rats. Hepatology 40:583–589

    Article  PubMed  CAS  Google Scholar 

  38. Casillas-Ramirez A, Amine-Zaouali M, Massip-Salcedo M, Padrissa-Altés S, Bintanel-Morcillo M, Ramalho F, Serafín A, Rimola A, Arroyo V, Rodés J, Roselló-Catafau J, Peralta C (2008) Inhibition of angiotenin II action protects steatotic liver against ischemia–reperfusion injury. Crit Care Med 36:1256–1266

    Article  PubMed  CAS  Google Scholar 

  39. Dezfulian C, Raat N, Shiva S, Gladwin MT (2007) Role of anion nitrite in ischemia–reperfusion cytoprotection and therapeutics. Cardiovasc Res 75:327–388

    Article  PubMed  CAS  Google Scholar 

  40. Lang JD Jr, Teng X, Chumley P, Crawford JH, Isbell TS, Chacko BK, Liu Y, Jhala N, Crowe DR, Smith AB, Cross RC, Frenette L, Kelley EE, Wilhite DW, Hall CR, Page GP, Fallon MB, Bynon JS, Eckhoff DE, Patel RP (2007) Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest 117:2583–2591

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors of have nothing to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Valentin Fuhrmann.

Additional information

The study was performed at the intensive care units 13H1, 13H3, and 13I2 of the Medical University of Vienna.

Appendix

Appendix

See Fig. 1 and Table 5

Fig. 1
figure a

Cumulative survival rate of 118 admissions with hypoxic hepatitis and 948 admissions without hypoxic hepatitis. Survival was significantly higher in patients without hypoxic hepatitis (log rank test)

Table 5 Main underlying admission diagnosis stratified according to the presence or absence of vasopressor therapy

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fuhrmann, V., Kneidinger, N., Herkner, H. et al. Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med 37, 1302–1310 (2011). https://doi.org/10.1007/s00134-011-2248-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-011-2248-7

Keywords

Navigation